Teva Pharmaceutical Industries Limited (TEVA) Presents at Leerink Global Healthcare Conference 2026 Transcript

Core Insights - The company has been implementing a "Pivot to Growth" strategy for three years, aimed at reversing a trend of decline and transitioning from a generics-focused business to a biopharmaceutical leader [2]. Group 1: Strategy Overview - The "Pivot to Growth" strategy consists of three phases: returning to growth, accelerating growth, and transforming the company into a world-class biopharma entity. The company is currently in the acceleration phase [2]. - The strategy is built on four pillars: enhancing the growth engine through increased sales of innovative products, stepping up innovation to expedite product market entry, creating a generics powerhouse, and focusing on capital allocation [3].